US stock · US markets · public data

UTHR

United Therapeutics Corp · Healthcare

Reference price$541.38Updated according to the public source
P/E19.41
P/B3.61
ROE19.31%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 23.2 B
Volume (shares)618,270
SectorHealthcare
Overview

About UTHR

Demonstrações públicas consolidadas + SEC Company Facts

United Therapeutics Corp (UTHR) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$2,327,500,000.00$2,877,400,000.00$3,182,700,000.00—
Gross Profit$2,070,000,000.00$2,567,700,000.00$2,798,300,000.00—
Operating Income$1,184,900,000.00$1,377,000,000.00$1,492,500,000.00—
Net Income$984,800,000.00$1,195,100,000.00$1,334,700,000.00—
EPS Diluted$19.81 / share$24.64 / share$27.86 / share—

Balance sheet

Account2023202420252026
Total Assets$7,167,000,000.00$7,364,000,000.00$7,880,000,000.00—
Total Liabilities$1,182,200,000.00$920,000,000.00$783,800,000.00—
Total Equity$5,984,800,000.00$6,444,000,000.00$7,096,200,000.00—
Shares Outstanding46,301,656 shares47,058,545 shares44,912,177 shares43,827,686 shares
Cash & Investments$4,903,900,000.00$4,742,300,000.00$4,697,000,000.00—

Cash flow

Account2023202420252026
Operating Cash Flow$978,000,000.00$1,327,100,000.00$1,561,200,000.00—
Capital Expenditures$230,400,000.00$246,500,000.00$520,500,000.00—
Free Cash Flow$747,600,000.00$1,080,600,000.00$1,040,700,000.00—
FAQ

Frequently asked questions

What is the price of UTHR?

The reference price available for UTHR is $541.38.

What is the P/E of UTHR?

The P/E ratio of UTHR is 19.41. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of UTHR?

The P/B of UTHR is 3.61. This compares price with reported book value per share.

What is the ROE of UTHR?

The ROE (Return on Equity) of UTHR is 19.31%. This relates the reported net result to shareholders' equity.

What is the dividend yield of UTHR?

The dividend yield of UTHR is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of UTHR?

The market capitalization of UTHR is US$ 23.2 B.

What sector is UTHR in?

UTHR operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.